Top Story

Kidney Social
Artificial Intelligence
AI model reveals kidney tumor features, potential for treatment response prediction
Researchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.
Featured
Breast Cancer3 Social
Breast Cancer
Consumer genetic testing may misrepresent breast cancer risk: Study
Dna Genome Gene Targeted Social
Financing
Rome Therapeutics raises $72M in series B financing
Latest News
Lab Scientists Social
NIH to require international collaborators to share all data
September 22, 2023
At-home or Lab-based STI testing/collection
Sponsored
At-home or Lab-based STI testing/collection
September 6, 2023
Bacteria Mycobacterium Tuberculosis Social
Danaher cuts cost of rapid TB test after years of pressure from activists
September 21, 2023
Parkinsons Lewy Bodies Social
Protein biomarker may aid in early Parkinsonian disorders detection
September 21, 2023
Dna Genome Gene Targeted Social
Financing
Rome Therapeutics raises $72M in series B financing
Regulatory Guidance
NIH to require international collaborators to share all data
Financing
Day Zero Diagnostics completes $16M financing round
Financing
Broken String Biosciences raises $15M in series A financing round
Kidney Social
Artificial Intelligence
AI model reveals kidney tumor features, potential for treatment response prediction
Breast Cancer
Consumer genetic testing may misrepresent breast cancer risk: Study
Financing
Rome Therapeutics raises $72M in series B financing
Informatics
Many British health trusts slow to adopt electronic records systems, shows BMJ survey
Breast Cancer3 Social
Breast Cancer
Consumer genetic testing may misrepresent breast cancer risk: Study
Financing
Rome Therapeutics raises $72M in series B financing
Tuberculosis
Danaher cuts cost of rapid TB test after years of pressure from activists
Parkinson's
Protein biomarker may aid in early Parkinsonian disorders detection
More from LabPulse.com
Ibex Medical Analytics launches AI-powered breast cancer biomarker scoring platform
Ibex Medical Analytics has launched a breast cancer biomarker scoring tool powered by artificial intelligence (AI) to help clinicians with treatment decisions.
September 11, 2023
Breast Specialist Ultrasound Exam Social
Researchers develop at-home device for diagnosing gingivitis
Researchers at the University of Cincinnati in Ohio are developing a device people can use at home to diagnose gingivitis.
September 12, 2023
Inflamed Gums Man Social
NIH study shows value of repeat use of COVID-19 antigen tests
Researchers have published the performance data that prompted the U.S. Food and Drug Administration to revise its position on COVID-19 testing last year.
September 11, 2023
Covid Diagnostic Test Kit Social
Proteomics study finds plasma proteins linked with type 2 diabetes, diabetic complications
An analysis of plasma proteins found to be linked with type 2 diabetes and diabetic complications may help develop therapeutic targets, researchers write in an article published in Cell Reports Medicine.
September 8, 2023
Diabetes Woman Lancet Social
Cell-penetrating peptide selectively kills melanoma cells in study
Scientists have voiced fresh hopes for metastatic skin cancer therapy after identifying a way to kill melanoma cells efficiently and selectively while sparing normal cells, according to a recent study.
September 8, 2023
Melanoma Social
Illumina names new CEO
Illumina has appointed Agilent Technologies’ Senior Vice President Jacob Thaysen as CEO, effective September 25.
September 8, 2023
Businessman Applaud Social
Guardant 360 CDx receives approval in Japan for NSCLC
The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved the Guardant360 CDx liquid biopsy test as a companion diagnostic for select patients with HER2-mutant NSCLC who are eligible for treatment with the antibody drug conjugate Enhertu.
September 7, 2023
Lung Cancer Hotspot Social
Roche’s Alecensa improves survival in postsurgery lung cancer patients in late-phase trial
Roche’s Alecensa has improved disease-free survival in non-small cell lung cancer patients, positioning the Swiss drugmaker to apply to expand the product label.
September 8, 2023
Cancer Lung Social
Actome outlines sequencing expansion plans as EU funding kicks in
Actome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”
September 7, 2023
Single Cell Analysis Social
Exact Sciences, Watchmaker Genomics partner to improve DNA methylation technology
Exact Sciences has partnered with Watchmaker Genomics to develop and commercialize technology for analyzing DNA methylation.
September 6, 2023
Dna Genome Gene Targeted Social
LabGenomics USA acquires QDx Pathology
In a strategic move to expand its North American market, LabGenomics USA, a subsidiary of South Korea-based LabGenomics, has acquired diagnostic and molecular service provider QDx Pathology.
September 6, 2023
Business Handshake Man Social
Ga. lab owner sentenced for $463M Medicare testing fraud scheme
Ga. lab owner Minal Patel was sentenced to serve 27 years in prison following his December 2022 conviction for his role in a $463 million Medicare fraud scheme.
September 8, 2023
Handcuffs Gavel Social